Data · dataset · 2026
Discovery and development of novel antimicrobials from gastrointestinal tract microbiomes
Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32637702.v1
The need to develop novel antimicrobials against bacterial pathogens of extreme clinical importance is an extremely pressing issue.
Description
Developing long-term strategies for the treatment of bacterial pathogens such as Acinetobacter baumannii to minimise antimicrobial resistance development is necessary for future infection control and ensuring longer lifespans for antimicrobials within healthcare settings. However there is still a need to develop innovative pipelines for the discovery of novel antimicrobials to provide treatment options in the future.
Exploring non-small molecule therapies such as antimicrobial peptides (AMPs) can provide an additional dimension to the compounds currently being developed for the clinic.<br><br>This thesis focused on utilising AMPs from gastrointestinal microbiomes, specifically the rumen of the domesticated cow and greater kudu, and the caecal environment from the domesticated chicken. These three groups of AMPs were in various stages of development, from the published Lynronne AMPs through to novel AMP sequences identified as part of this research project specifically to target A. baumannii.
Read the rest (2 more)
All three groups underwent a variety of characterisation assays to determine their efficacy and potential as treatments for infections caused by A. baumannii. These assays included activity and structural determinations, performance against survival mechanisms exhibited by A. baumannii, mechanistic studies, transcriptomic analysis and toxicity determinations, amongst others.<br><br>All three groups (containing Lynronne-1, -2 -3, K1, K14, K16, CHK_9, CHK_56, CHK_77 and CHK_103) produced candidates with high therapeutic potential and comprehensive datasets for each AMP were generated.
All 10 AMPs exhibited strong performance against A. baumannii, with the majority showing notable anti-biofilm properties and low toxicity. The performance demonstrated by both previously identified AMPs and novel AMPs also strengthens the case for utilising AMPs within clinical settings, and the methods of in silico identification will allow for future rapid identification and development of targeted antimicrobials to treat antimicrobial resistant clinical infections.
Links
Where it is published
- DOI doi.org/10.17034/32637702.v1 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
Provenance · 3 source records, 7 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/32637702 | 13 d ago | JSON v1 |
| Deakin Research Online | oai:figshare.com:article/32637702 | 13 d ago | JSON v1 |
| DMU Figshare | oai:figshare.com:article/32637702 | 13 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · figshare dmu ac uk | connector:figshare_dmu_ac_uk@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · dro deakin edu au | connector:dro_deakin_edu_au@1.0.0 | |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license_text | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |